Perfusion NewswireBiologics ZoneIn Vivo Protamine Titration Using Activated Coagulation Time to Neutralize Heparin Anticoagulation in Cardiac Surgery: Proof of Concept
In Vivo Protamine Titration Using Activated Coagulation Time to Neutralize Heparin Anticoagulation in Cardiac Surgery: Proof of Concept
We randomly assigned 240 patients undergoing elective cardiac surgery to receive up to 50 ml kg-1 day-1 of either HA, HES, or Ringer's lactate (RL) as the main infusion fluid perioperatively.
Harvest Technologies’ case in the U.S. District Court in Massachusetts is proceeding to trial on the issue of the invalidity of Cytomedix, Inc’s U.S. Patent No. 5,165,938 (the Knighton Patent).
